These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15517941)

  • 1. [beta-blockers in the treatment of hypertension in diabetic patients].
    Kobusiak-Prokopowicz M
    Pol Merkur Lekarski; 2004 Apr; 16(94):389-93. PubMed ID: 15517941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy.
    Deedwania PC
    Cardiol Clin; 2005 May; 23(2):139-52. PubMed ID: 15694743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-adrenergic blockade and diabetes mellitus. A review.
    Ostman J
    Acta Med Scand Suppl; 1983; 672():69-77. PubMed ID: 6138937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Do beta-blockers prevent coronary events in hypertensive patients?].
    Diévart F; Ragot S; Julien J; Herpin D
    Arch Mal Coeur Vaiss; 2005 Sep; 98(9):881-8. PubMed ID: 16231574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing treatment of diabetes and cardiovascular disease with combined alpha,beta-blockade.
    Bell DS
    Curr Med Res Opin; 2005 Aug; 21(8):1191-200. PubMed ID: 16083528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Do beta-blockers have a role in the modern treatment of arterial hypertension?].
    Horký K
    Vnitr Lek; 1996 Jun; 42(6):420-5. PubMed ID: 8928415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microalbuminuria, insulin resistance, diabetes, hypertension, and kidney function: the latest concepts in pathology and pharmacologic treatment.
    Barri YM; Palmer BF; Ram CV
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):34-45. PubMed ID: 19667709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Control of blood sugar and beta blockers in the diabetic patient].
    Albert J; Ekoe JM
    Sem Hop; 1983 Nov; 59(42):2939-43. PubMed ID: 6140758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up.
    Almgren T; Wilhelmsen L; Samuelsson O; Himmelmann A; Rosengren A; Andersson OK
    J Hypertens; 2007 Jun; 25(6):1311-7. PubMed ID: 17563546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with the discontinuation of evidence-based cardiovascular therapies in patients with stable coronary artery disease: a primary care perspective.
    Mostaza JM; Lahoz C; Martín-Jadraque R; Sanmartín MA; Vicente I; Tranche S; Taboada M; Mantilla T; Monteiro B; Sanchez-Zamorano MA;
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):34-8. PubMed ID: 19237995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effects of antihypertensive treatment with beta-blockers.
    Sawicki PT; Berger M
    J Intern Med Suppl; 1991; 735():97-9. PubMed ID: 1675055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How useful are beta-blockers in cardiovascular disease?
    Bangalore S; Parkar S; Messerli FH
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):358-63. PubMed ID: 17162285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are we misunderstanding beta-blockers.
    Cruickshank JM
    Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes.
    Brogan GX; Peterson ED; Mulgund J; Bhatt DL; Ohman EM; Gibler WB; Pollack CV; Farkouh ME; Roe MT
    Diabetes Care; 2006 Jan; 29(1):9-14. PubMed ID: 16373888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive treatment with beta-blockers and the spectrum of glycaemic control.
    Sarafidis PA; Bakris GL
    QJM; 2006 Jul; 99(7):431-6. PubMed ID: 16766516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
    Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
    Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.
    Schelleman H; Klungel OH; Witteman JC; Breteler MM; Yazdanpanah M; Danser AH; Hofman A; van Duijn CM; de Boer A; Stricker BH
    Eur J Hum Genet; 2007 Apr; 15(4):478-84. PubMed ID: 17299437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotection with beta-blockers: myths, facts and Pascal's wager.
    Messerli FH; Bangalore S; Yao SS; Steinberg JS
    J Intern Med; 2009 Sep; 266(3):232-41. PubMed ID: 19702791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus.
    Bangalore S; Parkar S; Grossman E; Messerli FH
    Am J Cardiol; 2007 Oct; 100(8):1254-62. PubMed ID: 17920367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.